Chris Boshoff, Senior Vice President of Immuno-Oncology, Translational and Early Development at Pfizer, and colleagues Samra Turajlic and Charles Swanton from the Francis Crick Institute and University College London give us their personal point of view on new insights and future therapeutic approaches for renal cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170181 | PMC |
| http://dx.doi.org/10.1084/jem.20181617 | DOI Listing |
Publication Analysis
Top Keywords
kidney cancer
4
cancer decade
4
decade chris
4
chris boshoff
4
boshoff senior
4
senior vice
4
vice president
4
president immuno-oncology
4
immuno-oncology translational
4
translational early
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!